Projects funded by the NCN
Immunomodulatory properties of nanosystems containing membrane-active compounds and their potential in therapy of drug resistant cancers.
2015/19/N/NZ6/01872
Keywords:
cancer immunology nanotechnology drug resistance
Descriptors:
- NZ6_2: Clinical immunology
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ6_1: Adaptive and innate immunity
Panel:
NZ6 - Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution :
Uniwersytet Medyczny w Białymstoku, Wydział Lekarski z Oddziałem Stomatologii i Oddziałem Nauczania w Języku Angielskim
woj. podlaskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 10 - announced on 2015-09-15
Amount awarded: 148 800 PLN
Project start date (Y-m-d): 2016-09-05
Project end date (Y-m-d): 2020-05-04
Project duration:: 44 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.